Global Minimally Invasive Surgical Instrument Market By Devices (Handheld Instruments, Inflation Devices, Cutter Instruments, and Other Devices), By Application (Whole, Crushed, Powder, and Other Application), By End-Use (Hospitals, and Ambulatory Surgical Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: Oct 2021
- Report ID: 14207
- Number of Pages: 310
- Format:
- keyboard_arrow_up
Minimally Invasive Surgical Instrument Market Overview:
The Global minimally invasive surgical instrument market was valued at USD 19,796 million in 2021. It is expected to grow at a CAGR of 10.1% between 2022 and 2032.
Surgical robotics has revolutionized minimally invasive surgery and is increasingly accepted by surgeons around the world. Minimally invasive surgery (MIS) costs are significantly lower than conventional open and in-patient surgeries. This results in significant value for both the patient and insurance companies. This trend will likely continue over the next few years. The forecast period will see robust growth opportunities due to the increasing number of products being launched and product approvals from market players in order to gain a greater market share. In India, Abbott introduced a minimally invasive device to repair heart valves in 2020.
Global Minimally Invasive Surgical Instrument Market Scope:
Device Analysis
With a more than 23.1% share of the minimally invasive surgical instrument market, the handheld instruments segment was the dominant market in 2021. The handheld instruments used in MIS procedures aim to reduce the damage to extraneous tissue during surgery, speeding up patient recovery and reducing side effects. The majority of instruments on the MIS market can only be used once.
Technological innovations are driving the handheld instrument market. They are also being used in minimally invasive surgery. A low-cost, mechanical instrument that can be used to perform minimally invasive laparoscopic surgery has been created recently. These handheld devices are either semi-automatic, mechanical, or robotic. These handheld devices make it easier to access instruments during triangulation surgery, which reduces the chance of making mistakes.
Application Analysis
With a market share of more than 24.1%, the orthopedic segment dominated in 2021. Orthopedic MIS procedures do not require the removal of muscles or bone. This has resulted in higher patient satisfaction and faster healing. Most commonly, MIS is used in hip and knee replacement surgeries. Surgeons and hospitals want to use surgical procedures that are less invasive and have fewer complications. This also means a shorter hospital stay. Pats, on the other hand, want surgical treatments that are less traumatizing and faster to recover from.
Cardiac surgery is a key factor in promoting minimally invasive procedures. There are many benefits to minimally invasive surgery over traditional surgeries. These include a reduced risk of infection, blood loss, pain and trauma reductions, fewer visible scars, quicker recovery times, shorter hospital stays, and quicker return to normal activities. Due to their many advantages, minimally invasive surgery is becoming more popular than conventional surgeries due to rising cardiovascular disease incidence.
End-Use Analysis
In 2021, the hospital segment was responsible for the highest revenue share at over 67.1%. The fastest expected growth rate for ambulatory surgical centers is expected over the forecast period. There are currently more than 5,500 Medicare-certified ambulatory surgical centers in the United States. Ambulatory surgical centers offer patients surgery at a lower cost and more flexibility than hospitals. These medical facilities are also known as same-day surgical centers. They can discharge patients following minor operations.
In the next few years, outpatient surgery is expected to increase dramatically. There are many factors that have contributed to the growth of ambulatory surgical centers, including advances in anesthesia and minimally invasive procedures. Also, there has been an improvement in patient experience, legislative changes, economic pressures, and a rise in legislation. Medicare removed the part B deductible to encourage the use of ambulatory surgical centers.
Кеу Маrkеt Ѕеgmеntѕ:
By Devices
- Handheld Instruments
- Inflation Devices
- Cutter Instruments
- Other Devices
By Application
- Whole
- Crushed
- Powder
- Other Application
By End-Use
- Hospitals
- Ambulatory Surgical Centers
Market Dynamics:
Minimally invasive procedures are less traumatizing than traditional open surgeries. Traditional laparoscopic surgeries can be difficult and traumatic. The minimally invasive laparoscopic camera is inserted through small incisions. Specialized smaller instruments are used for the operation. Patients can heal faster after minimally invasive surgery.
Because of their shorter recovery times, lower scarring, pain relief, improved accuracy, and shorter hospital stays, minimally invasive procedures are becoming more popular. Superior visibility of diagnostic images is possible with medical displays. They can show even the smallest differences in tissue and cells. This allows for precise and faster surgeries. The constant technological advances in this field have resulted in better instruments, which allow surgeons to perform surgical procedures efficiently and without risking patient safety. The new product designs allow for greater control and precision in the operating room. It’s highly effective in the treatment of breast and abdominal cancers, as well as for neurological, ophthalmic, and neurosurgical procedures. Because of its speedy healing, it is often preferred to open surgery.
Studies also suggest that Virtual Reality, when used with display devices in operating rooms, can improve the visualization and handling of tissues in inaccessible places, which ultimately leads to better accuracy during minimally invasive surgery. Virtual reality allows you to assess different conditions and possible treatment options for virtual patients before they are actually treated in a hospital setting. Instrumentation and video imaging have made it possible to improve many procedures across a range of surgical specialties, from open to endoscopic. Open exposures, such as wounds and infection after lumbar spine surgery, can be reduced using MIS techniques.
Market leaders such as Medtronic and Abbott have also launched robotic-assisted products. Medtronic, for example, entered into a definitive deal with Titan Medical in 2020 to develop robotic-assisted surgical technology. Abbott also launched a minimally invasive valve for the heart in 2020. India’s mitral regurgitation is treated with a repair device. IonicRF Generator is the company’s pain management product. It provides minimally invasive and non-surgical pain relief in the nervous system.
Regional Analysis:
North America dominated the MIS market’s regional segment in 2021, with a 44.1% revenue share. This was due to its high unintentional injury rate and large geriatric population. The Organization for Economic Cooperation and Development (OECD) reported that per capita healthcare spending in the United States is higher than in any other country in the world. Patients in the U.S. can choose their treatment methods and providers. This will likely have a positive effect on North America’s MIS market. The Asia Pacific, on the other hand, is expected to grow fastest between 2023 and 2032.
MIS procedures are expected to rise in the Asia Pacific due to the rising geriatric population of Japan and China, as well as road accidents and a developing economy. This region has a high demand for minimally invasive procedures, mainly because of the rising medical tourism mostly for cosmetic surgery.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Market Share & Key Players Analysis:
Due to the present leaders, the global market for minimally invasive surgical tools is highly competitive. Their revenue is mainly invested in R&D to create highly interactive technology that will strengthen their market position. To support product research and meet market needs, newer players in this market receive substantial funding from the government and healthcare organizations. Leaders use a variety of strategies to strengthen their market position, including acquisition, collaboration, and expansions. The following are some of the most prominent players in the global market for minimally invasive surgical tools:
Маrkеt Кеу Рlауеrѕ:
- Medtronic plc
- Siemens
- Healthineer AG
- Ethicon, Inc. (Johnson & Johnson)
- Depuy Synthes
- GE Healthcare
- Abbott Laboratories
- Intutive Surgical, Inc.
- Nuvasive, Inc.
- Zimmer Biomet
- Other Key Players
For the Minimally Invasive Surgical Instruments Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
Q: What is the size of the minimally invasive surgical instrument market in 2021?The Minimally invasive surgical instrument market size is US$ 19,796 million in 2021.
Q: What is the projected CAGR at which the Minimally invasive surgical instrument market is expected to grow at?The Minimally invasive surgical instrument market is expected to grow at a CAGR of 10.1% (2023-2032).
Q: List the segments encompassed in this report on the Minimally invasive surgical instrument market?Market.US has segmented the Minimally invasive surgical instrument market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Device, the market has been segmented into Handheld Instruments, Inflation Devices, Cutter Instruments, and Other Devices. By Application, the market has been further divided into Whole, Crushed, Powder, and Other Application. By End-Use, the market has been further divided into Hospitals and Ambulatory Surgical Centers.
Q: List the key industry players of the Minimally invasive surgical instrument market?Medtronic plc, Siemens, Healthineer AG, Ethicon, Inc. (Johnson & Johnson), Depuy Synthes, GE Healthcare, Abbott Laboratories, Intutive Surgical, Inc., and Other Key Players engaged in the Minimally Invasive Surgical Instrument market.
Q: Which region is more appealing for vendors employed in the Minimally invasive surgical instrument market?North America is expected to account for the highest revenue share of 44.1%. Therefore, the Minimally invasive surgical instrument industry in North America is expected to garner significant business opportunities over the forecast period.
Q: Name the key areas of business for Minimally invasive surgical instrument?The US, Canada, UK, India, China, Japan, & Germany are key areas of operation for the Minimally invasive surgical instrument Market.
Q: Which segment accounts for the greatest market share in the minimally invasive surgical instrument industry?With respect to the Minimally invasive surgical instrument industry, vendors can expect to leverage greater prospective business opportunities through the Handheld Instruments segment, as this area of interest accounts for the largest market share.
Minimally Invasive Surgical Instruments MarketPublished date: Oct 2021add_shopping_cartBuy Now get_appDownload Sample - Medtronic plc
- Siemens Aktiengesellschaft Company Profile
- Healthineer AG
- Ethicon, Inc. (Johnson & Johnson)
- Depuy Synthes
- GE Healthcare
- Abbott Laboratories
- Intutive Surgical, Inc.
- Nuvasive, Inc.
- Zimmer Biomet
- Other Key Players
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |